NASDAQ:PAGP • US72651A2078
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PLAINS GP HOLDINGS LP-CL A (PAGP).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-13 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-03-06 | Stifel | Maintains | Buy -> Buy |
| 2026-02-10 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-02-09 | Barclays | Maintains | Underweight -> Underweight |
| 2026-02-09 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-25 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-24 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-10-07 | Barclays | Maintains | Underweight -> Underweight |
| 2025-09-18 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-08-26 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-25 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2025-06-18 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-06-18 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-05-20 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-05-13 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-04-10 | Barclays | Maintains | Underweight -> Underweight |
| 2025-03-25 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-28 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-01-16 | Barclays | Maintains | Underweight -> Underweight |
| 2025-01-10 | Wolfe Research | Upgrade | Peer Perform -> Outperform |
| 2024-12-18 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2024-10-25 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-06-10 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-05-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-05-06 | Citigroup | Maintains | Neutral -> Neutral |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 48.712B -15.05% | 48.889B 0.36% | 44.262B -9.46% | 52.506B 18.63% | 53.052B 1.04% | 53.985B 1.76% | N/A | N/A | N/A | |
| EBITDA YoY % growth | 2.4B -4.80% | 2.047B -14.71% | N/A 41.43% | 2.822B -2.52% | 2.82B -0.07% | 2.923B 3.65% | 3.032B 3.73% | 3.083B 1.68% | 3.128B 1.46% | |
| EBIT YoY % growth | 1.349B -13.14% | 1.021B -24.31% | 1.374B 34.57% | 1.801B 31.08% | 1.95B 8.27% | 2.027B 3.95% | N/A | N/A | N/A | |
| Operating Margin | 2.77% | 2.09% | 3.10% | 3.43% | 3.68% | 3.75% | N/A | N/A | N/A | |
| EPS YoY % growth | 2.78 34.30% | 0.53 -80.94% | 1.38 160.38% | 1.70 23.02% | 1.86 9.53% | 2.01 8.26% | 1.98 -1.71% | 2.06 4.12% | 2.12 2.97% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.41 -3.28% | 0.41 173.70% | 0.37 -10.75% | 0.36 -9.48% | 0.39 -4.58% | 0.32 -21.74% | 0.35 -3.83% | 0.37 2.82% |
| Revenue Q2Q % growth | 13.152B 9.50% | 12.946B 21.65% | 12.442B 7.46% | 11.835B 12.02% | 11.921B -9.36% | 11.66B -9.93% | 12.527B 0.68% | 12.685B 7.18% |
| EBITDA Q2Q % growth | 732.03M -6.27% | 683.9M -8.20% | 700.96M -35.51% | 691.23M -9.97% | 740.94M 1.22% | 660.63M -3.40% | 746.29M 6.47% | 714.62M 3.38% |
| EBIT Q2Q % growth | 448.71M -13.54% | 424.32M 52.09% | 451.6M 15.50% | 460.07M 26.74% | 505.55M 12.67% | 427.01M 0.63% | 514.45M 13.92% | 484.43M 5.29% |
All data in USD
20 analysts have analysed PAGP and the average price target is 21.26 USD. This implies a price decrease of -9.14% is expected in the next year compared to the current price of 23.4.
PLAINS GP HOLDINGS LP-CL A (PAGP) will report earnings on 2026-05-07.
The consensus EPS estimate for the next earnings of PLAINS GP HOLDINGS LP-CL A (PAGP) is 0.41 USD and the consensus revenue estimate is 13.15B USD.
The expected long term growth rate for PLAINS GP HOLDINGS LP-CL A (PAGP) is 6.31%.